NCT06784687View on ClinicalTrials.gov

Evaluation of the Prevalence and Clinical Manifestation of SARS-CoV-2 Infection in a Population of Adult and Pediatric Patients With Congenital Heart Disease

CompletedOBSERVATIONAL

Enrollment

2,376

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

December 31, 2021

Conditions

Congenital Heart DiseaseCardiomyopathyPulmonary Arterial HypertensionSARS CoV-2 Infection

Trial Locations (1)

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT06784687 - Evaluation of the Prevalence and Clinical Manifestation of SARS-CoV-2 Infection in a Population of Adult and Pediatric Patients With Congenital Heart Disease | Biotech Hunter | Biotech Hunter